Credit Suisse’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $12.2M | Buy |
147,779
+1,810
| +1% | +$133K | 0.01% | 828 |
|
|
2023
Q4 | $9.74M | Buy |
145,969
+9,326
| +7% | +$604K | 0.01% | 934 |
|
|
2023
Q3 | $9.18M | Sell |
136,643
-2,654
| -2% | -$183K | 0.01% | 937 |
|
|
2023
Q2 | $9.43M | Buy |
139,297
+14,811
| +12% | +$928K | 0.01% | 954 |
|
|
2023
Q1 | $6.73M | Sell |
124,486
-3,203
| -3% | -$186K | 0.01% | 1127 |
|
|
2022
Q4 | $7.64M | Buy |
127,689
+27,447
| +27% | +$1.49M | 0.01% | 1054 |
|
|
2022
Q3 | $4.53M | Sell |
100,242
-24,405
| -20% | -$1.22M | 0.01% | 1315 |
|
|
2022
Q2 | $5.56M | Buy |
124,647
+4,239
| +4% | +$217K | 0.01% | 1214 |
|
|
2022
Q1 | $6.81M | Buy |
120,408
+6,475
| +6% | +$338K | 0.01% | 1255 |
|
|
2021
Q4 | $5.92M | Sell |
113,933
-8,222
| -7% | -$424K | ﹤0.01% | 1892 |
|
|
2021
Q3 | $7.29M | Buy |
122,155
+1,218
| +1% | +$76.6K | ﹤0.01% | 1758 |
|
|
2021
Q2 | $7.58M | Sell |
120,937
-14,409
| -11% | -$960K | ﹤0.01% | 1752 |
|
|
2021
Q1 | $8.82M | Buy |
+135,346
| New | +$8.83M | ﹤0.01% | 1662 |
|
|
2020
Q4 | – | Sell |
-19,935
| Closed | -$1.03M | – | 4354 |
|
|
2020
Q3 | $1.03M | Sell |
19,935
-30,477
| -60% | -$1.56M | ﹤0.01% | 2904 |
|
|
2020
Q2 | $2.48M | Buy |
+50,412
| New | +$2.72M | ﹤0.01% | 2211 |
|
|
2020
Q1 | – | Sell |
-200,799
| Closed | -$11.1M | – | 4040 |
|
|
2019
Q4 | $11.1M | Buy |
200,799
+74,351
| +59% | +$4.03M | 0.01% | 1354 |
|
|
2019
Q3 | $6.37M | Sell |
126,448
-57,364
| -31% | -$2.88M | 0.01% | 1582 |
|
|
2019
Q2 | $9.27M | Sell |
183,812
-41,930
| -19% | -$2.04M | 0.01% | 1355 |
|
|
2019
Q1 | $10.5M | Buy |
225,742
+51,333
| +29% | +$2.6M | 0.01% | 1214 |
|
|
2018
Q4 | $8.56M | Sell |
174,409
-4,648
| -3% | -$264K | 0.01% | 1239 |
|
|
2018
Q3 | $11.1M | Buy |
179,057
+3,376
| +2% | +$205K | 0.01% | 1197 |
|
|
2018
Q2 | $9.46M | Sell |
175,681
-96,702
| -36% | -$4.83M | 0.01% | 1271 |
|
|
2018
Q1 | $12.4M | Buy |
272,383
+12,888
| +5% | +$552K | 0.01% | 1126 |
|
|
2017
Q4 | $10.2M | Buy |
259,495
+13,871
| +6% | +$528K | 0.01% | 1277 |
|
|
2017
Q3 | $9.06M | Sell |
245,624
-10,022
| -4% | -$357K | 0.01% | 1311 |
|
|
2017
Q2 | $9.84M | Buy |
255,646
+29,851
| +13% | +$1.09M | 0.01% | 1215 |
|
|
2017
Q1 | $7.69M | Sell |
225,795
-6,110
| -3% | -$201K | 0.01% | 1357 |
|
|
2016
Q4 | $7.61M | Sell |
231,905
-26,210
| -10% | -$850K | 0.01% | 1381 |
|
|
2016
Q3 | $8.33M | Sell |
258,115
-13,686
| -5% | -$443K | 0.01% | 1319 |
|
|
2016
Q2 | $8.39M | Buy |
271,801
+111,752
| +70% | +$3.5M | 0.01% | 1281 |
|
|
2016
Q1 | $4.79M | Sell |
160,049
-72,437
| -31% | -$2M | 0.01% | 1561 |
|
|
2015
Q4 | $6.44M | Sell |
232,486
-64,432
| -22% | -$1.83M | 0.01% | 1409 |
|
|
2015
Q3 | $9.06M | Sell |
296,918
-37,117
| -11% | -$1.29M | 0.01% | 1174 |
|
|
2015
Q2 | $12.2M | Buy |
334,035
+76,023
| +29% | +$2.71M | 0.01% | 1115 |
|
|
2015
Q1 | $9.11M | Sell |
258,012
-61,323
| -19% | -$2.1M | 0.01% | 1257 |
|
|
2014
Q4 | $9.77M | Buy |
319,335
+44,115
| +16% | +$1.38M | 0.01% | 1302 |
|
|
2014
Q3 | $8.08M | Sell |
275,220
-149,373
| -35% | -$4.55M | 0.01% | 1428 |
|
|
2014
Q2 | $12.1M | Buy |
424,593
+104,811
| +33% | +$2.92M | 0.01% | 1252 |
|
|
2014
Q1 | $9.14M | Sell |
319,782
-54,184
| -14% | -$1.41M | 0.01% | 1314 |
|
|
2013
Q4 | $9.91M | Buy |
373,966
+101,019
| +37% | +$2.81M | 0.01% | 1286 |
|
|
2013
Q3 | $7.49M | Sell |
272,947
-77,443
| -22% | -$1.99M | 0.01% | 1328 |
|
|
2013
Q2 | $8.03M | Buy |
+350,390
| New | +$7.92M | 0.01% | 1267 |
|
Other funds holding EHC
Credit Suisse's EHC Position: Q1 2024 in Review
Credit Suisse increased its Encompass Health (EHC) stake by 1.2% in Q1 2024, buying an estimated $133K and bringing the position to 147,779 shares worth $12.2M. The position accounts for 0.01% of the portfolio, ranked #828.
Credit Suisse first reported a position in EHC in Q2 2013 and has held it in 42 quarters since. The position peaked at $12.4M in Q1 2018. 438 funds tracked by Wall St. Rank hold EHC as of Q1 2024.
- Credit Suisse held 147,779 shares of Encompass Health worth $12.2M as of Q1 2024.
- Credit Suisse bought 1,810 Encompass Health shares in Q1 2024, an estimated $133K.
- Encompass Health made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #828 holding.
- Credit Suisse first reported a position in Encompass Health in Q2 2013 and has held it in 42 quarters since.
- Credit Suisse's Encompass Health position peaked at $12.4M in Q1 2018.
- 438 funds tracked by Wall St. Rank held Encompass Health as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.